RCDP5
MCID: RHZ015
MIFTS: 35
|
Rhizomelic Chondrodysplasia Punctata, Type 5 (RCDP5)
Categories:
Bone diseases, Eye diseases, Fetal diseases, Genetic diseases, Mental diseases, Metabolic diseases, Neuronal diseases, Rare diseases
|
|
MalaCards integrated aliases for Rhizomelic Chondrodysplasia Punctata, Type 5:
Characteristics:OMIM:56
Inheritance:
autosomal recessive
Miscellaneous:
based on one report of 3 sibs and 1 unrelated patient of pakistani origin (last curated december 2015) HPO:31Classifications:
MalaCards categories:
Global: Genetic diseases Metabolic diseases Fetal diseases Rare diseases Anatomical: Neuronal diseases Eye diseases Bone diseases Mental diseases
Orphanet: 58
![]() ![]() ![]() ![]() ![]() |
OMIM :
56
Rhizomelic chondrodysplasia punctata (RCDP) is a peroxisomal disorder characterized by disproportionately short stature primarily affecting the proximal parts of the extremities, a typical facial appearance including a broad nasal bridge, epicanthus, high-arched palate, dysplastic external ears, and micrognathia, congenital contractures, characteristic ocular involvement, dwarfism, and severe mental retardation with spasticity. Biochemically, plasmalogen synthesis and phytanic acid alpha-oxidation are defective. Most patients die in the first decade of life (summary by Wanders and Waterham, 2005).
For a discussion of genetic heterogeneity of rhizomelic chondrodysplasia punctata, see 215100. (616716)
MalaCards based summary : Rhizomelic Chondrodysplasia Punctata, Type 5, also known as rhizomelic chondrodysplasia punctata type 5, is related to rhizomelic chondrodysplasia punctata and rhizomelic chondrodysplasia punctata, type 1. An important gene associated with Rhizomelic Chondrodysplasia Punctata, Type 5 is PEX5 (Peroxisomal Biogenesis Factor 5), and among its related pathways/superpathways are Acyl chain remodelling of PE and triacylglycerol biosynthesis. Affiliated tissues include bone and eye, and related phenotypes are global developmental delay and microcephaly Disease Ontology : 12 A rhizomelic chondrodysplasia punctata that has material basis in autosomal recessive inheritance of homozygous or compound heterozygous mutation in the PEX5 gene on chromosome 12p13.31. UniProtKB/Swiss-Prot : 73 Rhizomelic chondrodysplasia punctata 5: A form of rhizomelic chondrodysplasia punctata, a disease characterized by severely disturbed endochondral bone formation, rhizomelic shortening of femur and humerus, vertebral disorders, dwarfism, cataract, cutaneous lesions, facial dysmorphism, and severe mental retardation with spasticity. |
Human phenotypes related to Rhizomelic Chondrodysplasia Punctata, Type 5:31 (showing 23, show less)
Symptoms via clinical synopsis from OMIM:56Clinical features from OMIM:616716 |
Interventional clinical trials:(showing 1, show less)
|
MalaCards organs/tissues related to Rhizomelic Chondrodysplasia Punctata, Type 5:40
Bone,
Eye
|
Articles related to Rhizomelic Chondrodysplasia Punctata, Type 5:(showing 2, show less)
|
ClinVar genetic disease variations for Rhizomelic Chondrodysplasia Punctata, Type 5:6 (showing 2, show less)
|
Search
GEO
for disease gene expression data for Rhizomelic Chondrodysplasia Punctata, Type 5.
|
Pathways related to Rhizomelic Chondrodysplasia Punctata, Type 5 according to GeneCards Suite gene sharing:(showing 5, show less)
|
Cellular components related to Rhizomelic Chondrodysplasia Punctata, Type 5 according to GeneCards Suite gene sharing:(showing 3, show less)
Biological processes related to Rhizomelic Chondrodysplasia Punctata, Type 5 according to GeneCards Suite gene sharing:(showing 8, show less)
Molecular functions related to Rhizomelic Chondrodysplasia Punctata, Type 5 according to GeneCards Suite gene sharing:(showing 3, show less)
|
|